• Satellos and iCo Announce Completion of Reverse Takeover firstwordpharma
    August 16, 2021
    Satellos Bioscience Inc. (formerly iCo Therapeutics Inc.) (TSXV: MSCL) ("Satellos" or the "Company") is pleased to announce the completion, following the receipt of the final order of the Supreme Court of British Columbia on August 5, 2021.
PharmaSources Customer Service